The effects of analytical factors on second trimester risk estimations

International Journal of Gynecology and Obstetrics

Volumn 93, Issue 1, 2006, Pages 28-32

  Serdar, M A ^a   Tutuncu L ^a   Olgun, A ^a   Hasimi A ^a   Ozgurtas T ^a   Erbil, M K ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Down's syndrome; Risk estimation; Triple test

Indexed keywords

EID: 33645903210     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2005.12.026     Document Type: Article

References (13)

1. Wald N.J., Cuckle H.S., Densem J.W., Nanchahal K., Royston P., Chard T., et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297 (1988) 883-887
2. Haddow J.E., Palomaki G.E., Knight G.J., Williams J., Pulkkinen A., Canick J.A., et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 327 9 (1992) 588-593
3. Cavalli P. False-negative results in Down's syndrome screening. Lancet 347 6 (1996) 965-966
4. Williams K.L., Nix B.A., and Dunstan F.D. Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's syndrome screening. Ann Clin Biochem 37 (2000) 165-173
5. Christiansen M., Hogdall E.V., Larsen S.O., and Hogdall C. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down's syndrome. Prenat Diagn 22 5 (2002) 385-387
6. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986;7;1(8493):1287-93.
7. Holding S. Biochemical screening for Down's syndrome. BMJ 302 (1991) 1275
8. Benn P.A., and Collins R. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome. Ann Clin Biochem 38 (2001) 28-36
9. Reynolds T. Practical problems in Down syndrome screening: what should I do about gestation dating? What is effect of laboratory imprecision. Commun Lab Med 1 (1992) 31-38
10. Zarr J.H. Biostatistical Analysis. third ed. (1996), Prentice Hall, New Jersey 38
11. MacRae A.R., Gardner H.A., Allen L.C., Tokmakejian S., and Lepage N. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application. Clin Chem 49 1 (2003) 69-76
12. Cuckle H., Densem J., and Wald N. Repeat maternal serum testing in multiple marker Down's syndrome screening programmes. Prenat Diagn 14 7 (1994) 603-607
13. Muller F., Thalabard J.C., Ngo S., and Dommergues M. Detection and false-positive rates of maternal serum markers for Down syndrome screening according to maternal age in women over 35 years of age. A study of the agreement of eight dedicated software packages. Prenat Diagn 22 5 (2002) 350-353